Biotechnology is estimated to Witness High Growth Owing to Advancement in Gene Therapies

The Biotechnology market involves development of healthcare products by using techniques of modern biology and genetic engineering. The market comprises development of pharmaceuticals, genetically modified crops and biofuels. Biotechnology has transformed the diagnosis, treatment and prevention of diseases.

The Global Biotechnology Market is estimated to be valued at US$ 820.4 billion in 2023 and is expected to exhibit a CAGR of 12.3% over the forecast period 2023 to 2030.

Key Takeaways

Key players operating in the Biotechnology are Abbott Laboratories, Amgen Inc., GlaxoSmithKline, Johnson and Johnson, Merck, Novartis, Novo Nordisk, Pfizer, Inc., Roche, and Sanofi – Aventis. Key players in the market are focusing on development of gene therapies for treatments of chronic diseases like cancer.

Biotechnology Market Demand is being fueled by an increase in funding for research and development activities from both private and public sources, creating opportunities for innovation. Advancements in gene therapies, regenerative medicines, and personalized medicines are expected to drive the growth of the biotechnology market during the forecast period.

Market drivers

Rising prevalence of chronic diseases globally is the major driver for the biotechnology market. As per WHO, chronic diseases accounted for around 60% of the total reported deaths in the world in 2001. Biologics and biosimilars have emerged as effective treatment options for diseases like cancer, diabetes and autoimmune disorders. Increasing adoption of biologics due to their high efficiency and fewer side effects is expected to fuel the growth of the biotechnology market during the forecast period.

Current challenges in Biotechnology Market

The biotechnology market is currently facing challenges like high R&D costs, stringent regulatory requirements, and shortage of skilled workforce. Biotechnology R&D involves extensive research, clinical trials, and regulatory approvals which makes it a highly capital intensive endeavor. Any delays can significantly impact project timelines and budgets. Further, regulatory processes are becoming more complex with evolving safety and efficacy standards globally. This increases regulatory compliance burden on companies. There is also a growing gap between availability of specialized biotech talent and industry demand. All these factors can impede innovation and market growth in the short term.

SWOT Analysis

Strength: Advanced technologies like gene editing, artificial intelligence, and bioinformatics enable development of novel therapies.

Weakness: High dependency on public funding for early stage R&D. Costly and time-consuming clinical trials process.

Opportunity: Rising healthcare spending, increasing lifestyle diseases, and growing geriatric population driving market opportunity. Partnerships and M&A activities help companies access new technologies and markets.

Threats: Need for specialized infrastructure and stringent regulatory norms raise entry barriers. Trade barriers and IP issues affect global partnerships and market access.

The US and European regions currently account for over 70% share of the global biotechnology market in terms of value. This is due to strong academic research base, availability of funding, and presence of leading biotech companies in these regions. However, Asia Pacific region is emerging as the fastest growing market for biotechnology. Countries like China, India, South Korea are witnessing significant government investments and improving research ecosystem which is attracting global players to tap the market potential. Also, rising living standards and growing burden of non-communicable diseases in Asia drive the demand for biopharmaceuticals in the region.

Get This Report in Japanese Language - バイオテクノロジー市場

Get This Report in Korean Language - 생명공학 시장

About Author:

Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.

(LinkedIn: www.linkedin.com/in/alice-mutum-3b247b137 )